Drug Profile
Tripterygium wilfordii Hook F extract - Phytomedics
Alternative Names: PMI-001; TwHF extractLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Phytomedics
- Class Anti-inflammatories; Antirheumatics; Herbal medicines; Traditional Chinese medicine
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; Interleukin 2 inhibitors; Nitric oxide synthase type II inhibitors; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 11 Nov 2010 Phytomedics receives grant under the Qualifying Therapeutic Discovery Project Program for development of PMI 001 in Rheumatoid arthritis
- 21 Aug 2009 Clinical development is ongoing in USA
- 19 Aug 2009 Final efficacy and adverse events data from a phase II trial in Rheumatoid arthritis released by Phytomedics